169 related articles for article (PubMed ID: 37555799)
1. A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenoma.
Xing B; Lei Z; Wang Z; Wang Q; Jiang Q; Zhang Z; Liu X; Qi Y; Li S; Guo X; Liu Y; Li X; Shu K; Zhang H; Bartsch JW; Nimsky C; Huang Y; Lei T
Neuro Oncol; 2024 Jan; 26(1):137-152. PubMed ID: 37555799
[TBL] [Abstract][Full Text] [Related]
2. ADAM22, expressed in normal brain but not in high-grade gliomas, inhibits cellular proliferation via the disintegrin domain.
D'Abaco GM; Ng K; Paradiso L; Godde NJ; Kaye A; Novak U
Neurosurgery; 2006 Jan; 58(1):179-86; discussion 179-86. PubMed ID: 16385342
[TBL] [Abstract][Full Text] [Related]
3. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
[TBL] [Abstract][Full Text] [Related]
4. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network.
Yang J; Hou Y; Zhou M; Wen S; Zhou J; Xu L; Tang X; Du YE; Hu P; Liu M
Int J Biochem Cell Biol; 2016 Feb; 71():62-71. PubMed ID: 26693891
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: insights on ADAM function.
Liu H; Shim AH; He X
J Biol Chem; 2009 Oct; 284(42):29077-86. PubMed ID: 19692335
[TBL] [Abstract][Full Text] [Related]
6. A disintegrin and metalloprotease 22 accelerates neointima formation by activating ERK signaling.
Zhang SM; Jiang L; Zhao X; Liu JF; Liang B; Liu C; Liu N; Ma CS
Atherosclerosis; 2019 Apr; 283():92-99. PubMed ID: 30822685
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
8. Integrin β1 regulates proliferation, apoptosis, and migration of trophoblasts through activation of phosphoinositide 3 kinase/protein kinase B signaling.
Shu C; Han S; Hu C; Chen C; Qu B; He J; Dong S; Xu P
J Obstet Gynaecol Res; 2021 Jul; 47(7):2406-2416. PubMed ID: 33843127
[TBL] [Abstract][Full Text] [Related]
9. CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation.
Lu S; Lu T; Zhang J; Gan L; Wu X; Han D; Zhang K; Xu C; Liu S; Qin W; Yang F; Wen W
BMC Cancer; 2023 Mar; 23(1):290. PubMed ID: 36997926
[TBL] [Abstract][Full Text] [Related]
10. Ropivacaine inhibits the proliferation and migration of colorectal cancer cells through ITGB1.
Wang X; Li T
Bioengineered; 2021 Dec; 12(1):44-53. PubMed ID: 33345684
[TBL] [Abstract][Full Text] [Related]
11. ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma.
Li Y; Ren Z; Wang Y; Dang YZ; Meng BX; Wang GD; Zhang J; Wu J; Wen N
Exp Cell Res; 2018 Sep; 370(2):373-382. PubMed ID: 29966664
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts.
Wang C; Jiang X; Huang B; Zhou W; Cui X; Zheng C; Liu F; Bi J; Zhang Y; Luo H; Yuan L; Yang J; Yu Y
BMC Cancer; 2021 Nov; 21(1):1276. PubMed ID: 34823500
[TBL] [Abstract][Full Text] [Related]
13. hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation.
Hu C; Ni Z; Li BS; Yong X; Yang X; Zhang JW; Zhang D; Qin Y; Jie MM; Dong H; Li S; He F; Yang SM
Gut; 2017 Jan; 66(1):31-42. PubMed ID: 26370108
[TBL] [Abstract][Full Text] [Related]
14. THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway.
Guo D; Zhang D; Ren M; Lu G; Zhang X; He S; Li Y
FASEB J; 2020 Aug; 34(8):10668-10681. PubMed ID: 32567740
[TBL] [Abstract][Full Text] [Related]
15. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
[TBL] [Abstract][Full Text] [Related]
16. MMP-9 silencing regulates hTERT expression via β1 integrin-mediated FAK signaling and induces senescence in glioma xenograft cells.
Ponnala S; Chetty C; Veeravalli KK; Dinh DH; Klopfenstein JD; Rao JS
Cell Signal; 2011 Dec; 23(12):2065-75. PubMed ID: 21855630
[TBL] [Abstract][Full Text] [Related]
17. Biological characterization of ADAM22 variants reveals the importance of a disintegrin domain sequence in cell surface expression.
Sagane K; Sugimoto H; Akaike A
J Recept Signal Transduct Res; 2010 Apr; 30(2):72-7. PubMed ID: 20156119
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y
Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892
[TBL] [Abstract][Full Text] [Related]
19. Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration.
Zigrino P; Steiger J; Fox JW; Löffek S; Schild A; Nischt R; Mauch C
J Biol Chem; 2007 Oct; 282(42):30785-93. PubMed ID: 17704059
[TBL] [Abstract][Full Text] [Related]
20. β1 integrin mediates colorectal cancer cell proliferation and migration through regulation of the Hedgehog pathway.
Song J; Zhang J; Wang J; Wang J; Guo X; Dong W
Tumour Biol; 2015 Mar; 36(3):2013-21. PubMed ID: 25387809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
